An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
reductase in Glycine maxBactrocera dorsalisHibiscus syriacusAll 12 Gene records
Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet].
York (UK): Centre for Reviews and Dissemination (UK); 1995-.
Top results in this bookTable of Contents
Clinical Review Report: Icosapent Ethyl (Vascepa): (HLS Therapeutics Inc.): Indication: Prevention of cardiovascular events in statin-treated patients [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2020 Aug.
Pharmacoeconomic Review Report: Icosapent Ethyl (Vascepa): (HLS Therapeutics Inc.): Indication: Prevention of cardiovascular events in statin-treated patients [Internet].
StatPearls [Internet].
Treasure Island (FL): StatPearls Publishing; 2024 Jan-.
Therapeutics Letter.
Perry T, editor.
Vancouver (BC): Therapeutics Initiative; 1994-.
Screening for Cognitive Impairment in Older Adults: An Evidence Update for the U.S. Preventive Services Task Force [Internet].
Patnode CD, Perdue LA, Rossom RC, et al.
Rockville (MD): Agency for Healthcare Research and Quality (US); 2020 Feb. (Evidence Synthesis, No. 189.)
Endotext [Internet].
Feingold KR, Anawalt B, Blackman MR, et al., editors.
South Dartmouth (MA): MDText.com, Inc.; 2000-.
CADTH Canadian Drug Expert Committee Recommendation: Icosapent Ethyl (Vascepa — HLS Therapeutics Inc.): Indication: Prevention of cardiovascular events in statin-treated patients [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2020 Jul.
Evidence reviews for the investigation, management and follow-up of glioma: Brain tumours (primary) and brain metastases in adults: Evidence Report A.
National Guideline Alliance (UK).
London: National Institute for Health and Care Excellence (NICE); 2018 Jul. (NICE Guideline, No. 99.)
Drugs and Lactation Database (LactMed®) [Internet].
Bethesda (MD): National Institute of Child Health and Human Development; 2006-.
Multimorbidity: Assessment, Prioritisation and Management of Care for People with Commonly Occurring Multimorbidity.
National Guideline Centre (UK).
London: National Institute for Health and Care Excellence (NICE); 2016 Sep. (NICE Guideline, No. 56.)
LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet].
Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012-.
Evidence review for interventions for pre-eclampsia: Hypertension in pregnancy: diagnosis and management: Evidence review D.
London: National Institute for Health and Care Excellence (NICE); 2019 Jun. (NICE Guideline, No. 133.)
Screening for Prediabetes and Type 2 Diabetes Mellitus: An Evidence Review for the U.S. Preventive Services Task Force [Internet].
Jonas DE, Crotty K, Yun JDY, et al.
Rockville (MD): Agency for Healthcare Research and Quality (US); 2021 Aug. (Evidence Synthesis, No. 207.)
Optimal strategies for monitoring lipid levels in patients at risk or with cardiovascular disease: a systematic review with statistical and cost-effectiveness modelling.
Perera R, McFadden E, McLellan J, et al.
Southampton (UK): NIHR Journals Library; 2015 Dec. (Health Technology Assessment, No. 19.100.)
Description and Analysis of the VA National Formulary.
Institute of Medicine (US) VA Pharmacy Formulary Analysis Committee; Blumenthal D, Herdman R, editors.
Washington (DC): National Academies Press (US); 2000.
Non-Alcoholic Fatty Liver Disease: Assessment and Management.
London: National Institute for Health and Care Excellence (NICE); 2016 Jul. (NICE Guideline, No. 49.)
Cardiovascular Signaling in Health and Disease [Internet].
Parinandi NL, Hund TJ, editors.
Cham (CH): Springer; 2022.
Accuracy of glomerular filtration rate estimation using creatinine and cystatin C for identifying and monitoring moderate chronic kidney disease: the eGFR-C study.
Lamb EJ, Barratt J, Brettell EA, et al.
Southampton (UK): National Institute for Health and Care Research; 2024 Jul. (Health Technology Assessment, No. 28.35.)
Roflumilast (Zoryve): CADTH Reimbursement Review: Therapeutic area: Plaque psoriasis [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2023 Nov.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on